Biomage
Business Intelligence (BI) Software · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United KingdomWebsite
www.biomage.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Biomage
Biomage offers an end-to-end solution for single-cell RNA sequencing data analysis through its Cellenics platform, which allows users to process, visualize, and analyze data efficiently. The platform is designed for academic researchers, particularly in the fields of cancer, cardiovascular health, and developmental biology, providing a free community instance for small to medium-sized datasets. Biomage also collaborates with biotechs and pharmaceuticals to deliver customized data analysis workflows and technical support. Recently acquired by Parse Biosciences, Biomage is rebranding its Cellenics instance as Trailmaker, further enhancing its offerings in the single-cell technology space.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biomage your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Biomage launches new products
Congratulate Masked Content for being promoted to Masked Content at Biomage
Earning: See what the market has to say on Biomage recently announced quarterly report
Biomage, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Biomage has recently received funding, and reach out quickly before it becomes old news!
Click to see if Biomage had a recent Job posting/layoffs
Check out if Biomage is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Biomage has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Biomage
Compare insights from companies similar to Biomage, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Biomage
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Biomage is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Biomage is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Biomage.
Biomage Tech Stack
A closer look at the technologies used by Biomage
Biomage News & Media
Parse Biosciences Acquires Biomage
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software company Biomage. With the acquisition, customers will have access to a richer suite of single cell data analysis tools through an intuitive interface. By pairing Biomage’s powerful data analysis tools with Parse’s Evercode combinatorial barcoding technology, researchers gain deeper insights with a dramatically reduced
Read more news
Top Business Intelligence (BI) Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biomage
Sign Up For FreeTo access detailed company insights
Biomage offers an end-to-end solution for single-cell RNA sequencing data analysis through its Cellenics platform, which allows users to process, visualize, and analyze data efficiently. The platform is designed for academic researchers, particularly in the fields of cancer, cardiovascular health, and developmental biology, providing a free communi... Read More
